Cargando…
Prognostic biomarker SGSM1 and its correlation with immune infiltration in gliomas
OBJECTIVE: Glioma was the most common type of intracranial malignant tumor. Even after standard treatment, the recurrence and malignant progression of lower-grade gliomas (LGGs) were almost inevitable. The overall survival (OS) of patients with LGG varied widely, making it critical for prognostic pr...
Autores principales: | Li, Junsheng, Wang, Jia, Ding, Yaowei, Zhao, Jizong, Wang, Wen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9047296/ https://www.ncbi.nlm.nih.gov/pubmed/35484511 http://dx.doi.org/10.1186/s12885-022-09548-7 |
Ejemplares similares
-
Prognostic biomarker SYK and its correlation with immune infiltrates in glioma
por: Wang, Changxin, et al.
Publicado: (2023) -
Identification of heterogeneous subtypes and a prognostic model for gliomas based on mitochondrial dysfunction and oxidative stress-related genes
por: Li, Junsheng, et al.
Publicado: (2023) -
MELK is a prognostic biomarker and correlated with immune infiltration in glioma
por: Yang, Haiyan, et al.
Publicado: (2022) -
Prognostic Biomarker KIF18A and Its Correlations With Immune Infiltrates and Mitosis in Glioma
por: Tao, Bing-Yan, et al.
Publicado: (2022) -
High ECM2 Expression Predicts Poor Clinical Outcome and Promotes the Proliferation, Migration, and Invasiveness of Glioma
por: Li, Junsheng, et al.
Publicado: (2023)